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Long-term exposure to arsenic induces arsenical can-
cers in human beings. Arsenic has been shown to
induce apoptosis in a variety of cell systems.
Previous studies revealed that patients with arsenic-
induced Bowen's disease showed a defective cell-
mediated immunity and decreased percentages of T
cell and T helper cell subpopulations in peripheral
mononuclear cells. The purpose of this study was to
investigate the effects of arsenic on T cell survival
and function in mononuclear cells. Arsenic concen-
trations higher than 1 mM induced tumor necrosis
factor a release from mononuclear cells and caused a
cytotoxic effect on T cells. When exposed to higher
concentrations of arsenic, apoptosis was induced.
CD4+ cells were the major apoptoic population in
mononuclear cells. Tumor necrosis factor receptor 1
expression on CD4+ cells, but not Fas/FasL, was sig-
ni®cantly enhanced by arsenic treatment compared
to other mononuclear cells. Increased expressions of
tumor necrosis factor receptor 1 related death
domain proteins and activated caspases were
observed. These ®ndings indicate that tumor necrosis
factor receptor 1 signaling is the major pathway in
arsenic-induced T helper cell apoptosis. Key words:
cytokine/ cytokine receptor/ cytotoxicity/ lymphocytes/
sodium arsenite. J Invest Dermatol 119:812±819, 2002
A
rsenic is a well-established human carcinogen.
Epidemiologic studies demonstrated that long-term
exposure to inorganic arsenic through ingestion and
inhalation is associated with an increased risk of
malignant tumors developing in many organs, such as
the lung, stomach, liver, colon, kidney, and urinary bladder, in
addition to skin cancers (Chen et al, 1985). In vitro studies have
demonstrated that arsenic induces genetic and epigenetic effects
(Chen et al, 1997; Yih et al, 1997) as well as apoptosis in a variety of
cell systems. Arsenite is considered to be the most likely
carcinogenic form of arsenic (Rossman, 1998). Arsenite induces
chromosome aberrations, aneuploudy, and micronuclei (Rossman,
1999). Arsenite at nontoxic concentrations was found to act as a
comutagen with other agents. The comutagenic effects of arsenite
are probably the result of inhibition of DNA repair. Arsenite
inhibits the repair of DNA damage induced by X-rays and
ultraviolet (UV) radiation (Synder et al, 1989) and postreplication
repair of UV-induced damage (Lee-Chen et al, 1992).
Furthermore, arsenite potentiates X-ray and UV-induced chro-
mosomal damage in peripheral human lymphocytes and ®broblasts
(Jha et al, 1992).
A defective cell-mediated immune function is noticed in patients
with arsenical skin cancers. Impaired delayed-type hypersensitivity
response to 2,4-dinitrochlorobenzene, reduction in T cell and T
helper cell percentages, and a decrease in mitogenic responses of
peripheral mononuclear cells (MNCs) were found in arsenic-
induced Bowen's disease. The defective cell-mediated immune
function in Bowen's disease is due to impairment of membrane
interleukin-2 (IL-2) receptor expression in lymphocytes after
chronic arsenic exposure (Yu et al, 1998). Arsenic induced biphasic
effects on lymphocyte mitogenesis. There was an ampli®cation of
response at lower concentrations and an inhibition of mitogenesis at
higher concentrations of arsenic (McCabe et al, 1983; Yu et al,
1992). Arsenic has been shown to induce apoptosis in leukemic
cells (Chen et al, 1996; Wang et al, 1998; Zhang et al, 1998), plasma
cell lines and myeloma cells (Rousselot et al, 1999), esophageal
carcinoma cells (Shen et al, 1999), immortalized human cervical
epithelial cells (Zheng et al, 1999), and umbilical vein endothelial
cells (Roboz et al, 2000). One of the important mechanisms of
apoptosis is regulated by death receptor associated death domain
signaling intermediates, which contain receptor activation induced
binding of death domain proteins, such as tumor necrosis factor
(TNF) receptor-associated death domain protein (TRADD) and
Fas-associated death domain protein (FADD), and further acti-
vation of caspase cascades that initiate apoptotic death (Wallach et
al, 1999). A major apoptotic signal in MNCs is mediated by TNF-
a and its receptor. Signaling by TNF receptor causes the association
of an adapter protein TRADD with the intracellular death domain
of the TNF receptor 1 (TNF-R1) molecule (Hsu et al, 1996;
Ashkenazi and Dixit, 1998). TRADD mediates the subsequent
recruitment of an adapter protein FADD to form a death-inducing
signaling complex, which initiates apoptosis through activation of
caspase cascades. The purpose of this study was to investigate the
effects of arsenic on human peripheral MNC functions and T cell
apoptosis. We found that arsenic stimulated TNF-a release from
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MNCs and TNF-R1 signaling plays a major role in arsenic-
induced T helper cell apoptosis.
MATERIALS AND METHODS
Isolation of MNCs and arsenic treatment Venous blood was
collected from 12 healthy adults (25±40 y old). MNCs were isolated
from heparinized venous blood of these donors after centrifugation at
300 3 g for 20 min over a Ficoll-Hypaque cushion (speci®c gravity
1.077) as reported previously (Yu et al, 1989). Freshly obtained MNCs
were suspended in RPMI-1640 medium (Gibco, Gaithersburg, MD)
containing 10% fetal bovine serum and adjusted to a concentration of
1.0 3 106 cells per ml. Sodium arsenite (Sigma, St. Louis, MO) in
phosphate-buffered saline (PBS) was then added to ®nal concentrations
of 0.01, 0.1, 0.5, 1, 5, or 10 mM. Arsenic-treated MNCs were cultured
at 37°C in a humidi®ed incubator with 5% CO2 atmosphere. The
following experiments were performed in triplicate.
Cell viability assay The commercially available kit for cell
proliferation (XTT assay kit; Roche, Mannheim, Germany) was used
according to the manufacturer's instruction. Freshly prepared MNCs
were seeded into 96-well plates (1.0 3 106 cells per ml) and various
concentrations of sodium arsenite were added in triplicate. After 24, 48,
or 72 h of treatment, the XTT reagents were then added into each well
and incubated at 37°C for 4 h to generate colorimetric formazan
products. Absorbance of formazan product was measured at a wavelength
of 450 nm with a reference wavelength of 630 nm (Jost et al, 1992). The
results were expressed as relative cell viability.
Measurement of cytokines in culture supernatants by enzyme-
linked immunosorbent assay (ELISA) After 48 h of arsenic
treatment, cultured MNCs were centrifuged at 2000 rpm for 10 min and
the cell-free supernatants were obtained for cytokine measurement.
TNF-a and interferon-g (IFN-g) were determined using commercially
available ELISA kits (Quantikine, R&D Systems, Minneapolis, MN)
according to the manufacturer's instructions.
DNA laddering analysis for apoptosis The DNA fragmentation
analysis (DNA ladder) was assessed by agarose gel electrophoresis
according to Enari et al (1998) with a slight modi®cation. Arsenic-treated
or control MNCs (2 3 106 cells) were collected and centrifuged at
1200 rpm for 5 min and then resuspended in a lysis buffer [50 mM Tris±
HCl pH 8.0, 5 mM ethylenediamine tetraacetic acid (EDTA), 1.2%
sodium dodecyl sulfate, 150 mM NaCl, 0.2 mg per ml proteinase K]
followed by incubation at 37°C overnight. Cellular DNA was isolated by
phenol extraction and the DNA samples were carefully loaded into the
wells of a 2.0% agarose gel. Electrophoresis was carried out in TAE
Figure 1. Effects of arsenic on MNC viability. Freshly obtained
normal human MNCs were seeded (106 cells per ml) in 96-well
microplates, treated with different concentrations of sodium arsenite (in
PBS), and incubated in a CO2 incubator at 37°C for 24 h, 48 h or 72 h.
The cell viability was analyzed by XTT assay. Cell viability was rapidly
decreased with arsenic exposures higher than 1 mM and about 50% of
the MNCs died when exposed to 5 mM of arsenic for 48 h and 72 h.
Viability of the control group (no arsenic added; PBS only) after 24 h,
48 h or 72 h incubation was taken as 100% (mean 6 SD; n = 18).
Figure 2. Effects of arsenic on TNF-a and IFN-g release from
MNCs. After 48 h of 0 (control), 1, 5, and 10 mM of arsenic exposure,
the MNC supernatant (per 106 cells) was collected and the
concentrations of cytokines were measured with commercialized ELISA
kits. The white bars are concentrations of TNF-a; IFN-g is shown as
black bars (pg per ml). Both IFN-g and TNF-a were increased with
exposure to 1 mM of arsenic; at 5 mM, IFN-g release was inhibited but
the release of TNF-a was further stimulated. All data in the ELISA test
were measured by linear regression standard curves in which r2 should
larger than 0.99 (mean 6 SD; n = 12).
Figure 3. Agarose gel electrophoresis analysis of apoptotic DNA
fragments. Cultured MNCs were exposed to arsenic for 48 h, and then
cellular DNA was isolated. Total DNA from MNC samples was loaded
into a 2% agarose gel for electrophoresis at 50 V for 1 h. 180 bp DNA
ladders were observed as a typical feature for apoptosis. At 5 and 10 mM
of arsenic treatment, DNA patterns showed a typical feature of apoptotic
DNA ladders in agarose gel (M, 100 bp DNA marker; C, control).
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buffer at 50 V for 1 h and the DNA was visualized by ethidium bromide
staining.
Flow cytometric analysis of MNC populations, apoptotic
subpopulations, and apoptosis-related receptors Populations of
lymphocytes in MNCs were determined by ¯ow cytometric analysis.
Brie¯y, arsenic-treated and control MNCs were stained with CD3-PE,
CD19-FITC, CD4-FITC, or CD8-FITC antibodies (Becton Dickinson,
San Jose, CA) in an ice-bath for 30 min and then ®xed with 4%
paraformaldehyde (in PBS), and the percentages of each population were
measured by ¯ow cytometry (ESP, Couter, Miami, FL) (Yu et al, 1998).
To distinguish the apoptotic cells from MNC populations, a TUNEL
kit (Roche, Mannheim, Germany) was used. Arsenic-treated and control
MNCs were stained with phycoerythrin (PE) conjugated antibodies
against CD4, CD8, or CD19 (Becton Dickinson) and ®xed with 4%
paraformaldehyde. After washing twice with PBS, the cells were
incubated in permeabilization solution (0.1% Triton X-100 in 0.1%
sodium citrate) for 2 min on ice. Permeabilized cells were washed with
PBS and 50 ml of TUNEL reaction mixture (contains terminal deox-
ynucleotidyl transferase and nucleotide mixture) was added to each
sample. A 60 min reaction at 37°C was required to label the DNA strand
breaks with ¯uorescein isothiocyanate (FITC). The CD4-PE or CD8-
PE/TUNEL-FITC double stained MNCs were washed and percentages
of positively stained cells were analyzed by ¯ow cytometry.
The ¯ow cytometric method was also used in the determination of
TNF-R1, TNF-R2, and Fas/FasL expression on MNCs. MNCs were
collected and stained with FITC-conjugated monoclonal anti-TNF-R1,
anti-TNF-R2, anti-Fas, or anti-FasL antibodies. After washing twice
with PBS, CD3-PE, CD19-PE, CD4-PE, or CD8-PE were then stained.
The double stained MNCs were washed with PBS, ®xed with 4%
paraformaldehyde (in PBS), and analyzed by ¯ow cytometry.
TNF receptor blocking test Freshly isolated MNCs (107 cells) were
suspended in 0.45 ml culture medium, and 50 ml of polyclonal anti-TNF
receptor antibody (1 mg per ml; PeproTech, Rocky Hill, NJ) was
added. After 30 min incubation at 37°C, the MNC±antibody solution
was diluted with 9.5 ml of culture medium to adjust to 1.0 3 106 cells
per ml MNCs and 5 mg per ml of antibody concentration. This
antibody-containing cell suspension was then transferred into 96-well
plates and cultured at different arsenic concentrations. After 48 h culture,
cell viability was measured by XTT assay.
Western blotting analysis of apoptosis-associated proteins For
sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western
blotting of FADD, TRADD, and caspases, total cellular protein extract
from MNCs was obtained by lysing the cells in ice-cold lysis buffer
(50 mM Tris, 5 mM EDTA, 0.1% Triton X-100, 150 mM NaCl, and
mixed cocktail of protease inhibitors). After 12,000 rpm centrifugation to
remove cell debris, supernatants were collected and the protein
concentrations were measured by protein quanti®cation kit (Bio-Rad,
Hercules, CA). 40 mg total protein of each sample was subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis (using 12.5%
acrylamide gels). Proteins on polyacrylamide gels were then transferred
onto a nitrocellulose membrane (Bio-Rad). The membrane was blocked
in 2% skim milk/PBS with 0.5% Tween-20 for 1 h at room temperature
and incubated with primary and secondary antibodies. Polyclonal
antibodies against human TRADD, FADD, caspase 8, caspase 3, and
poly ADP ribose polymerase (PARP) (Santa Cruz Biotechnology, Santa
Cruz, CA) were used at a dilution of 1:500 in the blocking solution.
The chemiluminescence substrate kit (Pierce, Rockford, IL) was used
to visualize the presence of speci®c proteins in the nitrocellulose
membrane.
Statistical analysis All values are presented as mean 6 SD. The
comparisons of lymphocyte populations and subpopulations among
control and test groups were assessed using the unpaired Student's t test.
A p-value of < 0.05 was considered as statistically signi®cant.
RESULTS
Arsenic revealed cytotoxicity in MNCs Freshly prepared
MNCs were exposed to various concentrations of sodium arsenite
and incubated for 24 h, 48 h, and 72 h at 37°C. Arsenic
concentrations lower than 1 mM showed no signi®cant effect on
Table I. Effects of arsenic on MNCs
Treatment
Percentage of cell populations
CD3+ (T cells) CD19+ (B cells) CD3+/CD4+ (T helper) CD3+/CD8+ (T cytotoxic)
Effects of arsenic on CD3 and CD19 populations in MNCsa
Control 75.1 6 2.8 19.3 6 1.6
As 1 mM 77.4 6 4.3 17.8 6 2.5
As 5 mM 61.7 6 3.2c 18.8 6 2.7
Effects of arsenic on CD4+ and CD8+ T cells (CD3+, CD4, or CD8 single positive) subpopulations in MNCsb
Control 40.5 6 4.2 36.1 6 2.4
As 1 mM 38.4 6 4.1 37.8 6 3.1
As 5 mM 28.6 6 3.7c 35.4 6 2.0
aForty-eight hour incubated control cells 1 mM or 5 mM arsenic exposed cells were double stained with CD3-PE and CD19-FITC. Percentages of cell populations were
measured by ¯ow cytometry. A decrease in CD3+ cell percentage was noticed in the 5 mM arsenic-treated group.
bCells were double stained with CD3-PE/CD4-FITC or CD3-PE/CD8-FITC. Percentages of cell populations were measured by ¯ow cytometry. A decrease in T helper
cell percentage was noticed in the 5 mM arsenic-treated group.
cp < 0.05 (mean 6SD; n = 12).
Table II. Flow cytometric analysis of apoptotic MNC
subpopulations affected by arsenica
Treatment
Percentage of apoptotic cells (TUNEL+)
CD4+ CD8+ CD19+
Control 3.5 6 1.3 2.8 6 1.0 3.3 6 1.4
As 1 mM 4.8 6 1.7 4.2 6 1.4 2.8 6 1.2
As 5 mM 12.6 6 0.8b 5.4 6 1.1 4.1 6 1.8
aCultured MNC with or without arsenic exposure for 48 h and double stained
with TUNEL/CD4, TUNEL/CD8, or TUNEL/CD19. The data showed CD4+
cells were the major apoptotic subpopulation in MNC by arsenic.
bp < 0.05 (mean 6SD; n = 12).
Table III. Flow cytometric analysis of TNF-R1 expression
in T cell subpopulationsa
TNF-R1 expression (mean ¯uorescence intensity)
CD4+ CD8+
Control 35.9 6 1.5 31.0 6 0.8
As 1 mM 36.2 6 1.2 32.3 6 1.7
As 5 mM 44.1 6 2.1b 29.7 6 1.6
aAfter 48 h incubation, MNCs were double stained with TNF-R1/CD4 or
TNF-R1/CD8. Mean ¯uorescence intensity of TNF-R1 was analyzed. Arsenic
enhanced TNF-RI expression on CD4+ cells but not on CD8+ cells.
bp < 0.05 (mean 6SD; n = 12).
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Figure 4. Flow cytometric analysis of TNF-R1+ percentage in T cell subpopulations. After 48 h incubation, MNCs were double stained with
TNF-R1/CD4 or TNF-R1/CD8 and percentages of TNF-R1+ cells were analyzed. Arsenic enhanced TNF-RI expression on CD4+ cells but not on
CD8+ cells. Arsenic 5 mM stimulated a signi®cant increase in TNF-R1 expression on CD4+ cells.
Table IV. Apoptosis-associated receptors expressed on CD4+ cells by ¯ow cytometrya
Fas FasL TNF-R1 TNF-R2
Control 2.2% 6 1.8% 0.9% 6 0.7% 2.1% 6 1.2% 1.6% 6 0.3%
As 1 mM 4.5% 6 2.4% 1.1% 6 0.2% 3.2% 6 1.4% 1.7% 6 0.5%
As 5 mM 7.1% 6 5.3% 0.1% 6 0.1% 15.2% 6 2.7%b 0.7% 6 0.2%
aAfter 48 h incubation, MNC were double stained with CD4 and each receptor/ligand. All data in this table are for CD4+ cells and the percentage of expression in each
receptor/ligand was compared with the control group. TNF-R1 is the only signi®cant apoptosis-related receptor expressed on CD4+ cells by 5 mM arsenic.
bp < 0.05 (mean 6SD; n = 12).
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MNC survival by XTT assay. At 1 mM arsenic, about 10% increase
in cell viability was noticed both at 48 h and 72 h incubation, but
not at 24 h. Cell viability rapidly decreased when arsenic
concentrations were higher than 1 mM. At 48 h and 72 h
incubation, arsenic concentrations lower than 1 mM revealed a
similar pattern in cell viability. 50% cell viability was noticed at
5 mM arsenic at both 48 h and 72 h incubation (Fig 1). Therefore,
in this study we chose 0, 1, and 5 mM arsenic and 48 h incubation
for the apoptosis assay. This concentration-dependent effect of
arsenic on MNC viability was also con®rmed by trypan blue
exclusion and BrdU incorporation assays (data not shown).
Arsenic induced TNF-a release from MNCs Effects of
arsenic on the release of proin¯ammatory cytokines, i.e., TNF-a
and IFN-g, were studied by ELISA. The results showed that TNF-
a and IFN-g were signi®cantly stimulated by arsenic. As shown in
Fig 2, both IFN-g release (28.8 6 7.1 pg per ml) and TNF-a
release (46.1 6 5.0 pg per ml) were increased by exposure to
1 mM of arsenic. In contrast, at 5 mM, IFN-g release was inhibited
but the release of TNF-a was further stimulated (74.2 6 9.8 pg
per ml). These results indicated that TNF-a might play an
important role in arsenic-induced cell death.
Arsenic induced MNC apoptosis In order to clarify the type
of cell death induced by arsenic, an agarose gel electrophoresis was
performed. We found that 5 and 10 mM of arsenic were able to
induce DNA fragmentation, which showed a typical feature of
apoptotic DNA ladders in agarose gel (Fig 3). In parallel, TUNEL
staining was performed and revealed the same results (data not
shown).
Arsenic induced CD4+ cell apoptosis To identify the cell
populations that were affected by arsenic, percentages of cell
populations in MNCs were analyzed using ¯ow cytometry. CD3
and CD19 were used as markers to detect T cells and B cells,
respectively. As shown in Table I(a), CD3+ cells were
signi®cantly decreased by 5 mM arsenic treatment. We further
analyzed the subpopulations in CD3+ cells using CD4 (T helper)
and CD8 (T cytotoxic) markers. The results indicated that CD4+
cells were the target cells of arsenic (Table Ib). The TUNEL/
CD4, TUNEL/CD8, and TUNEL/CD19 double staining method
was then used to detect apoptotic populations in MNCs. As shown
in Table II, CD4+ cells were the major apoptotic subpopulation
induced by arsenic.
Arsenic stimulated a signi®cant increase in TNF-R1
expression on CD4+ cells In order to further con®rm if the
TNF pathway was involved in arsenic-induced apoptosis, we
studied TNF-R1 expressions on MNC populations. Arsenic
enhanced TNF-R1 expression on CD3+ cells but not other cell
populations, i.e., CD19+ B cells and CD14+ monocytes, in MNCs
(data not shown). Furthermore, arsenic enhanced both TNF-R1
expression intensity (Table III) and percentage (Fig 4) on CD4+
cells, but not on CD8+ cells. Other apoptosis-associated receptors,
such as Fas/FasL and TNF-R2, were also assayed and revealed no
signi®cant effects (Table IV). This result was con®rmed by a TNF
receptor inhibition assay. When TNF-R1 was blocked by a
polyclonal antibody, arsenic-induced cytotoxicity in MNCs was
inhibited (Fig 5), and TUNEL+ apoptotic CD4+ cells were
decreased (Fig 6). These results indicated that TNF-R1 is the
major apoptosis-related receptor expressed on CD4+ cells by
arsenic treatment.
Arsenic induced TNF-R1 signaling in MNCs TNF-R1-
associated apoptotic factors and caspases were detected by Western
blotting. The death domain proteins TRADD and FADD were
increased by arsenic treatment; in addition, the active forms of
caspase-8 and caspase-3 were also increased (Fig 7). Activated
caspase-3 can cleave its substrate PARP to 85 kDa and 16 kDa
fragments. In this study, at higher concentrations of arsenic, an 85
kDa fragment cleaved from PARP was observed (Fig 7). These
results indicated that TNF-R1 apoptotic signaling played a
signi®cant role in arsenic-induced CD4+ cell death.
DISCUSSION
Patients with arsenic-induced Bowen's disease showed a defective
cell-mediated immunity and decreased percentages of T cell and T
helper cell subpopulations in peripheral MNCs (Yu et al, 1992;
1998). In this study, concentrations higher than 1 mM revealed a
toxic effect on MNCs. Furthermore, higher concentrations of
arsenic induced T cell apoptosis with a signi®cant decrease in the
percentage of CD4+ T cells. This result is consistent with the
®nding of a reduction in T helper cell percentage in arsenic-
induced Bowen's disease (Yu et al, 1998). CD4+ cells were the
major apoptotic population in T cells. Arsenic at 1 mM stimulates
both TNF-a and IFN-g release from MNCs. TNF-a is mainly
released from monocytes/macrophages (Vassalli, 1992), and IFN-g
is produced by T helper cell type 1 (Constant and Bottomly, 1997).
Arsenic concentrations of 5 mM and 10 mM induce signi®cant
toxic effects including an apoptotic effect on T helper cells;
therefore IFN-g release is suppressed. On the other hand,
monocytes/macrophages are relatively resistant to arsenic and
TNF-a production is still stimulated by 5 mM and 10 mM
concentrations of arsenic. A slight but signi®cant increase in
TNF-a release between 1 mM and 5 mM is noticed. In contrast, a
dramatic increase in cell death exists between these two
concentrations. Clearly, TNF-a is not the only explanation
for apoptosis induced by arsenic. A concentration of 5 mM
arsenic induces a signi®cantly higher percentage of TNF-R1-
expressed CD4+ cells compared to 1 mM arsenic. In addition,
5 mM arsenic signi®cantly increases the mean ¯uorescence
intensity level in CD4+ cells. These ®ndings induced by
5 mM arsenic provide a reasonable explanation for the signi®-
cantly higher percentage of CD4+ cell apoptosis compared to
1 mM arsenic. Furthermore, the TNF receptor blocking test
revealed an antiapoptotic effect of 5 mM arsenic. Pretreatment
by anti-TNF-R1 antibody was able to inhibit arsenic-induced
cytotoxicity in MNCs and apoptosis in CD4+ cells. There is a
Figure 5. TNF receptor blocking test for arsenic-induced
cytotoxicity. Anti-TNF receptor antibody or control antibody treated
MNCs were cultured under 0, 1, 5, and 5 mM of arsenic exposure for
48 h. The cell viability was analyzed by XTT assay. Anti-TNF receptor
antibody revealed that arsenic-induced cytotoxicity at 5 mM arsenic in
MNCs was inhibited (*cell viability of anti-TNF receptor antibody versus
control antibody treated MNCs at the same arsenic concentration p <
0.05; mean 6 SD; n = 12).
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signi®cant decrease in both spontaneous and inducible TNF-a
and IFN-g production in MNCs in patients with arsenic-
induced Bowen's disease. This impaired cellular immunity is
due to defective IL-2 receptor expression induced by low-dose
and chronic exposure to arsenic (Yu et al, 1998). The different
release patterns of TNF-a and IFN-g between arsenic-induced
Bowen's disease and this study can be explained by different
concentrations and exposure periods of arsenic.
Active T cell apoptosis takes place indirectly by the antigen-
induced expression of death cytokines, chie¯y TNF and FasL/Apo-
1 L (Russell et al, 1991; Brunner et al, 1995; Zheng et al, 1995;
Nagata, 1997). Activation of the TNF with two distinct surface
receptors, TNF-R1 and TNF-R2 has been reported (Tartaglia and
Goeddel, 1992; Smith et al, 1994). Signaling by TNF-a is initiated
by binding to TNF-R1, which causes the association of death
domain proteins TRADD, FADD, etc. to form a death-inducing
Figure 6. TNF receptor blocking test for arsenic-induced CD4+ cell apoptosis. Anti-TNF receptor antibody or control antibody treated
MNCs were exposed to arsenic for 48 h. Then MNCs were double stained with TUNEL/CD4 and analyzed by ¯ow cytometry. The percentage of
TUNEL+/CD4+ cells is shown to compare the number of apoptotic CD4+ populations with different treatments. The TNF receptor blocking test
revealed an antiapoptotic effect on CD4+ cells at 5 mM arsenic.
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signaling complex that initiates apoptosis through activation of
caspase-8 (Muzio et al, 1996). Caspase-8 in turn induces activation
of caspase-3 and caspase-7, which cleave PARP, and of caspase-6,
which cleaves lamin B, thus contributing to dissolution of the
nuclear envelope (Mizushima et al, 1996; Dbaibo et al, 1997;
Nicholson and Thornberry, 1997; Cuvillier et al, 1998; Kimura and
Gelmann, 2000). TNF-R1 and TNF-R2 may mediate the
activation of independent downstream signaling pathways
(Engelmann et al, 1990; Tartaglia et al, 1991). TNF-R2 functions
primarily to bind ligand rapidly, passing soluble TNF trimers to
TNF-R1 (Tartaglia et al, 1993; Pinckard et al, 1997). Engagement
by FasL initiates a death signal by causing the aggregation of speci®c
cytoplasmic signaling proteins on the death domain of Fas. Fas
receptor interacts with FADD to initiate apoptosis through
activation of caspase cascades (Cohen, 1997; Sharma et al, 2000).
In this study, TNF-R1-related proteins, i.e., TRADD, FADD,
caspase-8, caspase-3, and cleavage of PARP were observed. On the
other hand, arsenic showed no signi®cant effect on TNF-R2
expression in either CD4+ cells or CD8+ cells. Although arsenic
revealed a slightly stimulatory effect on Fas expression in both
CD4+ and CD8+ cells, Fas ligand expression could not be detected
on either cell. The Fas/FasL system is not considered to be actively
involved in arsenic-induced apoptosis. Our results indicate that
TNF-R1 signaling plays a signi®cant role in CD4+ cell apoptosis
induced by arsenic. The release of TNF-a from MNCs is a
reasonable explanation for arsenic-induced CD4+ cell apoptosis.
There are two other possible mechanisms for an arsenic-initiated
TNF-R1 pathway in CD4+ cells. First, similar to some apoptosis-
inducing agents (Madge et al, 1999), arsenic may directly react with
TNF-R1. Second, arsenic may phosphorylate PEA-15 like proteins
(Estelles et al, 1999), therefore enhancing apoptosis via the TNF-
R1 cell death pathway. More investigation is needed to elucidate
the mechanisms, however.
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